About ASP Isotopes
ASP Isotopes (NASDAQ:ASPI) specializes in the production and distribution of isotopes used across various industries, including healthcare, research, and energy. The company focuses on innovative solutions to supply stable and radioactive isotopes, aiming to meet the growing global demand. ASP Isotopes is committed to sustainable practices and high safety standards in the handling and transportation of its products. The company's objectives include expanding its product range, enhancing production efficiency, and maintaining strong relationships with its customers and partners worldwide. Through strategic investments in technology and research, ASP Isotopes strives for excellence in delivering high-quality isotopes, contributing to advancements in medicine, scientific research, and clean energy solutions.
Snapshot
Operations
Products and/or services of ASP Isotopes
- Stable Isotope Production for research in physics, chemistry, and biology.
- Isotope Enrichment Services catering to medical, industrial, and environmental applications.
- Radiopharmaceuticals development for diagnostic and therapeutic uses.
- Custom Labeling Solutions for tracing in biochemical and pharmaceutical studies.
- Isotope Analysis Services for environmental monitoring and geological dating.
- Nuclear Medicine Support providing isotopes for cancer treatment and diagnostic imaging.
ASP Isotopes executive team
- Mr. Paul Elliot Mann C.F.A.Executive Chairman & CEO
- Ms. Heather KiesslingChief Financial Officer
- Mr. Robert AinscowChief Operating Officer
- Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D.Chief Technology Officer
- Mr. Nicholas Michael MitchellCo-Chief Operating Officer
- Mr. Donald George AinscowEVP, General Counsel & Secretary
- Mr. Hendrik T. van WykHead of Engineering
- Dr. Xandra van Heerden Ph.D.Head of Research & Development
- Mr. Stefano MaraniPresident of Electronics & Space
- Dr. Gerdus Kemp M.D., Ph.D.Medical Director & CEO of Pet Labs